Cargando…

Novel Antagonists of Heparin Binding Growth Factors

Detalles Bibliográficos
Autores principales:	Cecchi, Fabiola, Bottaro, Donald P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660056/ https://www.ncbi.nlm.nih.gov/pubmed/22989865

Ejemplares similares

Fibrogenic Effects of Heparin-Binding Epidermal Growth Factor-like Growth Factor: Myeloid or Epithelial Origin?
por: Martin, James G., et al.
Publicado: (2022)

Heparin Inhibits Hepatocyte Growth Factor Induced Motility and Invasion of Hepatocellular Carcinoma Cells through Early Growth Response Protein 1
por: Ozen, Evin, et al.
Publicado: (2012)

Heparin-binding protein in sepsis: player! predictor! positioning?
por: Honore, Patrick M., et al.
Publicado: (2019)

Multiple influences of a heparin-binding growth factor on neuronal development
Publicado: (1987)

Endothelial Cell Capture of Heparin-Binding Growth Factors under Flow
por: Zhao, Bing, et al.
Publicado: (2010)

To heparinize or not to heparinize: Effect on arterial blood gas measurements
por: Lobo, Valentine
Publicado: (2014)

Rilotumumab Resistance Acquired by Intracrine Hepatocyte Growth Factor Signaling
por: Cecchi, Fabiola, et al.
Publicado: (2023)

Preservation of heparin-binding EGF-like growth factor activity on heparin-modified poly(N-isopropylacrylamide)-grafted surfaces
por: Kobayashi, Jun, et al.
Publicado: (2021)

Laminin heparin-binding peptides bind to several growth factors and enhance diabetic wound healing
por: Ishihara, Jun, et al.
Publicado: (2018)

Heparin-binding epidermal growth factor-like growth factor suppresses experimental liver fibrosis in mice
por: Huang, Guangcun, et al.
Publicado: (2012)

Activated mesothelial cells produce heparin-binding growth factors: implications for tumour metastases
por: Jayne, D G, et al.
Publicado: (2000)

A heparin-modified thermoresponsive surface with heparin-binding epidermal growth factor-like growth factor for maintaining hepatic functions in vitro and harvesting hepatocyte sheets
por: Arisaka, Yoshinori, et al.
Publicado: (2016)

Synergistic anti-leukemic activity of imatinib in combination with a small molecule Grb2 SH2 domain binding antagonist
por: Zhang, Manchao, et al.
Publicado: (2013)

Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer
por: Yagi, H, et al.
Publicado: (2005)

Heparin-Binding Epidermal Growth Factor-like Growth Factor/Diphtheria Toxin Receptor in Normal and Neoplastic Hematopoiesis
por: Vinante, Fabrizio, et al.
Publicado: (2013)

Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
por: Poli, Maura, et al.
Publicado: (2017)

Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2
Publicado: (1996)

Generation and Characterization of Conditional Heparin-Binding EGF-Like Growth Factor Knockout Mice
por: Oyagi, Atsushi, et al.
Publicado: (2009)

Heparin binding preference and structures in the fibroblast growth factor family parallel their evolutionary diversification
por: Li, Yong, et al.
Publicado: (2016)

Surviving Covid-19 with Heparin?
por: ten Cate, Hugo
Publicado: (2021)

Heparin Cofactor II: A Novel Plausible Link of Obesity and Diabetes with Thrombosis
por: Hasegawa, Yutaka, et al.
Publicado: (2017)

Detection of high levels of heparin binding growth factor-1 (acidic fibroblast growth factor) in inflammatory arthritic joints
Publicado: (1990)

Autocrine expression of the epidermal growth factor receptor ligand heparin-binding EGF-like growth factor in cervical cancer
por: Schrevel, Marlies, et al.
Publicado: (2017)

HEPARIN-BINDING EGF-LIKE GROWTH FACTOR PROMOTES EPITHELIAL-MESENCHYMAL TRANSITION IN HUMAN KERATINOCYTES
por: Stoll, Stefan W., et al.
Publicado: (2012)

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
por: Li, Junsheng, et al.
Publicado: (2005)

The Soluble Heparin-Binding EGF-Like Growth Factor Stimulates EGF Receptor Trafficking to the Nucleus
por: Korotkevych, Nataliia V., et al.
Publicado: (2015)

Serum Amphiregulin and Heparin-Binding Epidermal Growth Factor as Biomarkers in Patients with Idiopathic Inflammatory Myopathy
por: Hanata, Norio, et al.
Publicado: (2021)

Intercellular crosstalk in adult dental pulp is mediated by heparin-binding growth factors Pleiotrophin and Midkine
por: Jiravejchakul, Natnicha, et al.
Publicado: (2023)

Possible dissociation of the heparin-binding and mitogenic activities of heparin-binding (acidic fibroblast) growth factor-1 from its receptor-binding activities by site-directed mutagenesis of a single lysine residue
Publicado: (1990)

Advances in Heparins and Related Research. An Epilogue
por: Fareed, Jawed, et al.
Publicado: (2018)

Locally administered heparin-binding epidermal growth factor-like growth factor reduces radiation-induced oral mucositis in mice
por: Chen, Jing, et al.
Publicado: (2020)

Fibroblast growth factor 23, klotho and heparin
por: Thomas, S. Madison, et al.
Publicado: (2023)

Evaluating the immunogenicity of heparin and heparin derivatives by measuring their binding to platelet factor 4 using biolayer interferometry
por: Chen, Qingqing, et al.
Publicado: (2022)

Carboxyl‐terminal Heparin‐binding Fragments of Platelet Factor 4 Retain the Blocking Effect on the Receptor Binding of Basic Fibroblast Growth Factor
por: Sato, Yasufumi, et al.
Publicado: (1993)

Heparin-binding epidermal growth factor-like growth factor and hepatocyte growth factor inhibit cholestatic liver injury in mice through different mechanisms
por: Sakamoto, Kouichi, et al.
Publicado: (2016)

CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor
Publicado: (1995)

Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells
por: OTA, ICHIRO, et al.
Publicado: (2013)

Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapy
por: Ling, Ling, et al.
Publicado: (2015)

Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor()()
por: Stawowczyk, Marcin, et al.
Publicado: (2016)

New developments in the characterization of heparin and its impurities
por: Larive, Cynthia K.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_eib9r0a4q5t5ikkd7ur1i6j90u